Cargando…
Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial
BACKGROUND: Chronic chagasic cardiomyopathy is an inflammatory disease that occurs in approximately 30% of patients infected by the protozoan Trypanosoma cruzi, and it has a profile of high morbidity and mortality. The worst prognosis and the progression of this cardiomyopathy are associated with an...
Autores principales: | Silva, Paula S, Sperandio da Silva, Gilberto Marcelo, de Souza, Andréa P, Cardoso, Claudia SA, Fonseca, Cristiane A, Brito, Patricia D, Saraiva, Roberto M, Brasil, Pedro EA, Pinheiro, Roberta O, Hasslocher-Moreno, Alejandro M, Xavier, Sérgio S, Sousa, Andréa S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225749/ https://www.ncbi.nlm.nih.gov/pubmed/24216069 http://dx.doi.org/10.1186/1745-6215-14-379 |
Ejemplares similares
-
Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
por: Silva, Paula Simplício da, et al.
Publicado: (2017) -
A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018) -
Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012) -
Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial
por: Alvarenga Americano do Brasil, Pedro Emmanuel, et al.
Publicado: (2014) -
Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)